Aspen is the largest pharmaceutical company in Africa and and has a proud heritage dating back more than 160 years. It is committed to sustaining life and promoting healthcare through increasing access to its high quality, effective, affordable medicines and products.
The South African business provides a diverse basket of branded, generic, OTC, consumer health and infant nutritional products which are supplied to pharmacies, retail pharmacy chains, hospitals, clinics, prescribing specialists, dispensing general practitioners, managed healthcare funders and retail stores across the private and public sectors in South Africa.
Aspen’s product ranges cover a number of therapeutic categories. These include anaesthetics, analgesics, ARVs, blood and haemopoetic, cardio vascular system, central nervous system ear, nose and throat, endocrine system, gastro-intestinal tract, infant nutritional products, musculo-skeletal agents, NS aids, oncology, oral hygiene, respiratory system and urinary tract system and more.
Aspen has 26 pharmaceutical manufacturing facilities on 18 pharmaceutical manufacturing sites on 6 continents. Click here to view Aspen’s global manufacturing capabilities.
Aspen’s manufacturing centre is based in South Africa and facilities in Port Elizabeth and East London produce a high volume of tablets, capsules, liquids, semi-solids, eye drops, liquid vials, hormonal ampoules and vials, lyophilised vials, infant milk forumula and liquid UHT.
As at 30 June 2014, IMS valued the South African private pharmaceutical sector at R29,9 billion and Aspen was ranked as the number one pharmaceutical company in the private sector, with a 15,8% share. In the private sector, four out of the top 20 largest products was an Aspen product and four out of the top five generic products supplied in the private sector are for Aspen products. Almost one in every four scripts dispensed by South African pharmacists is for an Aspen product, as recorded by ImpactRx.